March 12, 2020 / 11:46 AM / 24 days ago

BRIEF-Aldeyra Therapeutics Provides Updates On Anticipated Clinical Milestones

March 12 (Reuters) - Aldeyra Therapeutics Inc:

* ALDEYRA THERAPEUTICS REPORTS FULL-YEAR 2019 FINANCIAL RESULTS AND PROVIDES UPDATES ON ANTICIPATED CLINICAL MILESTONES

* ALDEYRA THERAPEUTICS - STRATEGIC PRIORITIZATION OF LATE-STAGE OCULAR PIPELINE EXPECTED TO EXTEND CASH RUNWAY THROUGH END OF 2021

* ALDEYRA - TO PLACE ON HOLD CLINICAL DEVELOPMENT OF TOPICAL DERMAL REPROXALAP FOR TREATMENT OF ICHTHYOSIS ASSOCIATED WITH SJOGREN-LARSSON SYNDROME

* ALDEYRA THERAPEUTICS INC - TO PLACE ON HOLD ITS CLINICAL DEVELOPMENT OF ADX-1612 FOR TREATMENT OF POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below